Collaboration practices with renowned global research institutions and pharmaceutical companies, witnessing innovative applications of gene editing technology
4 cases in total
Leading Pharmaceutical Company
Tumor Drug Target Validation Project for Leading Pharmaceutical Company
PharmaceuticalOncology Drug Development
Using our high-throughput CRISPR/Cas9 RNP technology platform, we completed the construction of knockout cell lines for 20 targets within 2 weeks
Top-tier University School of Life Sciences
Signaling Pathway Research Project at Leading University
Academic ResearchBasic Research
Provided customized gene editing solutions, including 5 gene knockouts and 3 targeted knock-in cell lines
Biotechnology Company
PROTAC Drug Screening Platform for Biotech Company
BiotechnologyDrug Screening
Using our Harbor™ targeted integration platform, we efficiently constructed 710 HiBiT-tagged cell lines at safe harbor loci within 5 weeks
Multinational Pharmaceutical R&D Center
CAR-T Cell Therapy Research for Multinational Pharmaceutical Company
PharmaceuticalImmunotherapy
Using RNP electroporation method, successfully knocked out checkpoint genes including PD-1 and CTLA-4 in various immune cells such as T cells and NK cells